Komori
Other Disclosures4935LIBERTA CO.,LTD.Materials and Chemicals

Notice of the Launch of the New Skincare Brand “MEDiLiA”

LIBERTA CO.,LTD. has launched the new skincare brand “MEDiLiA” and plans to begin advance sales of 3 individually packaged serums on 7 August 2026. The full launch is scheduled for 14 September, with 2 additional products planned for release this autumn.

Worth reading
58In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

MEDiLiA (Medilia)MEDiLiA Shirotama Pure C ShotMEDiLiA Suikou ShotMEDiLiA LH-A ShotMEDiLiA P-DRN ShotMEDiLiA Azela Shot
Applicable field (uses covered by this announcement)
Daily skincareHome CareBeauty care inspired by aesthetic treatments
Launch dateAdvance sales scheduled to begin on 7 August 2026 (Friday), as stated in the text as the launch date. The full launch is scheduled for 14 September 2026. The 2 additional products are scheduled for release this autumn.
Relationship between the counterparty and the company
LIBERTA CO.,LTD.4935
Relationship with the Company

Leveraging the expertise of group company 株式会社アフラ

Offering price

Shirotama Pure C Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included)

Suikou Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included)

LH-A Shot: ¥1,980 / 14 sachets, ¥990 / 7 sachets (tax included)

P-DRN Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included)

Azela Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included)

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredMEDiLiA (Medilia), MEDiLiA Shirotama Pure C Shot, MEDiLiA Suikou Shot, MEDiLiA LH-A Shot, MEDiLiA P-DRN Shot, MEDiLiA Azela Shot
Relationship with the CompanyLeveraging the expertise of group company 株式会社アフラ
Offering priceShirotama Pure C Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included), Suikou Shot: ¥3,190 / 28 sachets, ¥990 / 7 sachets (tax included), LH-A Shot: ¥1,980 / 14 sachets, ¥990 / 7 sachets (tax included), P-DRN Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included), Azela Shot: ¥2,970 / 28 sachets, ¥990 / 7 sachets (tax included)
Launch dateAdvance sales scheduled to begin on 7 August 2026 (Friday), as stated in the text as the launch date. The full launch is scheduled for 14 September 2026. The 2 additional products are scheduled for release this autumn.
Applicable areaDaily skincare, Home Care, Beauty care inspired by aesthetic treatments
Items this document does not state (13)
CounterpartyCounterparty overviewContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide insights and ingredients from aesthetic treatments in a form that can be easily incorporated into daily home care. The company leveraged the expertise of group company 株式会社アフラ in developing cosmetics for aesthetic clinics and salons.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Launch of the New Skincare Brand “MEDiLiA” | LIBERTA CO.,LTD. (4935) timely disclosure | Komori